Nurses may claim up to 2.5 contact hours for this session.
University of Minnesota approves this knowledge-based activity for 2.5 contact hours (0.25 CEUs). UAN JA0000810-9999-19-082-L01-P. Initial Release Date: 12/7/19.
Epilepsy Therapies Symposium: Neurostimulation for Epilepsy: Which, When, Where and How?
There are now several options available for treating refractory epilepsy with neurostimulation. It can be difficult to decide when to use each one. We will briefly present a case, followed by presentations on the multiple clinically available neurostimulation modalities: responsive neurostimulation, deep brain stimulation, and vagus nerve stimulation. There will then be a presentation on what practicing neurologists should know about the FDA device clearance process. Then there will be a short talk on choosing a neurostimulation modality in 2019, followed by a panel discussion relating to the presented case, and audience Q&A.
Following participation in this activity, participants will be able to:
- Discuss the multiple neurostimulation modalities and better individualize the type of neurostimulation for a given patient
- Recognize the utility of chronic intracranial EEG recordings
- Counsel patients on the benefits and risks of responsive neurostimulation, vagus nerve stimulation, and deep brain stimulation
- Identify the FDA device clearance process and what "clearance" does and does not imply.
Co-chairs: Lawrence J. Hirsch, MD and Timothy Simeone, MD
Introduction and Short Case Presentation, Lawrence J. Hirsch, MD
Responsive Neurostimulation, Vikram R. Rao, MD, PhD
Deep Brain Stimulation, Robert Fisher, MD
Vagus Nerve Stimulation, Kristl Vonck, MD
What Epileptologists Should Know About FDA Device Approval, Carlos Peña, PhD
Putting It All Together: Choosing a Therapy in 2019, Selim Benbadis, MD
Panel Discussion and Conclusion Case, All Faculty
Panel Discussion and Conclusions, Timothy Simeone, MD